Compounds > etoposide
Page last updated: 2024-08-23

etoposide and kn 62

etoposide has been researched along with kn 62 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganapathi, R; Grabowski, D; Hidaka, H; Kawamura, K; Krivacic, K1
Dubyak, GR; Ganapathi, R; Grabowski, DR; Hidaka, H; Rybicki, L1
Aoyama, M; Bukowski, RM; Ganapathi, MK; Ganapathi, R; Grabowski, DR; Holmes, KA; Rybicki, LA1

Other Studies

3 other study(ies) available for etoposide and kn 62

ArticleYear
Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
    Biochemical pharmacology, 1996, Dec-24, Volume: 52, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antineoplastic Agents; Apoptosis; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; DNA Topoisomerases, Type II; Drug Resistance; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Topoisomerase II Inhibitors; Trifluoperazine

1996
Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes.
    Biochemical pharmacology, 1998, Aug-01, Volume: 56, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; DNA Damage; Drug Resistance, Neoplasm; Egtazic Acid; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Topoisomerase II Inhibitors

1998
Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes.
    Biochemical pharmacology, 2001, Jan-01, Volume: 61, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; DNA; DNA Damage; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans

2001